PRISM Mid-Day Movers: Biotech and NextGen Tech & AI are today’s Leaders.
Shares of CXApp Inc. (NASDAQ: CXAI) are climbing sharply today, up roughly 30% as traders respond to fresh news that the company has secured an additional 180‑day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement. The bounce comes on elevated volume and follows last week’s launch of the “One Map Experience” spatial‑intelligence layer for its AI‑powered workplace platform, a product push that, combined with the new compliance window through September 7, 2026, is fueling speculation that CXAI can leverage its enterprise AI positioning to stabilize the stock and avoid a potential delisting.
Shares of Polaryx Therapeutics, Inc. (NASDAQ: PLYX) are pushing higher again today, with the stock recently up around 30–35% intraday as momentum builds around this newly listed rare‑disease biotech. The move extends a strong post‑Nasdaq‑listing run driven by anticipation for the SOTERIA Phase 2 basket trial of lead candidate PLX‑200 across four lysosomal storage disorders—CLN2, CLN3, Krabbe disease, and Sandhoff disease—and by a steady cadence of awareness and community‑engagement updates that keep the program and its pediatric LSD focus in front of investors.
Other Notable Movers:
Biotricity (BTCY) up 19%
United States Antimony (UAMY) up 16%
HUB Security (HUBC) down -33%
